Torus palatinus (TP) is the most common exostosis of the maxillofacial skeleton. It usually does not cause symptoms, but removal may be required if it interferes with the function, denture placement, or suffers from recurring traumatic surface ulceration. Large variations in the prevalence of TP have been reported in different populations and were associated with age and sex. The aim of this study is to investigate the prevalence, size, and location of TP in a population of young Turkish. A total of 1,943 schoolchildren, 1,056 males and 887 females, ranging in age from 5 to 15 years were assessed for the prevalence, size and location of TP. Inspection and palpation were examined for the presence or absence of TP. The prevalence of the TP in study population was 30.9%. TP was found significantly more in females than in males (34.3, 28.1%, P<0.005). The more of TP were smaller than 2 cm (91.5%), and in molar location (62.9%). This study indicated that the prevalence of TP in Turkish population was high. There was a strong correlation between the prevalence of TP and age or sex.

There is no routinely determined treatment for olfactory dysfunction because of COVID-19. Saline irrigation and nasal corticosteroid treatments are safe and inexpensive methods, and have low side effects. In our study, we argue that saline nasal irrigation and topical corticosteroid treatment can be used in the treatment of patients with olfactory loss in all areas of rhinology. A total of 150 patients who admitted to our clinic with other symptoms or with only acute odor loss, diagnosed with COVID-19 with RT-PCR were divided into 3 equal groups.Fifty patients in Group 1 were not given any extra treatments. The other 50 patients in Group 2 were given saline irrigation for treatment; and the 50 people in Group 3 were given both saline irrigation and nasal steroid spray for treatment. The ''Subjective Olfactory Capability (SOC)'' was used for olfactory function evaluation of patients. Self-Rating Olfactory Score (SROS), and Olfactory Dysfunction Duration (ODD) were recorded on the 1st, 15th and 30th days. SROS of the group receiving Nasal Saline ? Triamcinolone Acetonide treatment on the 30th day was significantly higher than in other groups (p 21-3 = 0.018, p 223 = 0.033). Also, the ODD was significantly reduced in this group compared to other groups (p 21-3 = 0.022, p 223 = 0.028,). Topical triamcinolone treatment was found to be successful in the treatment of olfactory dysfunction due to COVID-19. Nasal steroids, which are both inexpensive and have low side effect profiles, can be used safely in the treatment of patients with olfactory losses.

Objectives: Besides the common symptoms of the coronavirus disease 2019 (COVID-19) including fever, shortness of breath, and cough, a “sudden loss of smell” has recently been added as a diagnostic symptom. The relationship between paranasal sinus computed tomography (PNS CT) and sudden loss of smell in COVID-19 was examined. Materials and Methods: Two groups were selected for the study, the COVID-19 and the control groups. The control group consisted of 40 patients who applied to our clinic with headache and therefore underwent PNS CT. The other group consisted of 40 patients with COVID-19 who were diagnosed with sudden loss of smell with the Connecticut Chemosensory Clinical Research Center (CCCRC) olfactory test. Clinical and demographic characteristics, tomography results, and olfactory test scores of patients with COVID-19 loss of smell and control group patients were recorded. The relationship between CT changes in the olfactory cleft and the degree of loss of smell was evaluated. The “Opacification in the olfactory cleft” was accepted as a positive CT finding. Results: Comparison of patients with COVID-19 who had a loss of smell and the control group indicated that a significant difference was observed in terms of CT findings ( P = .022). When we evaluated the paranasal CTs obtained from our patients with loss of smell, the CT of 13 patients showed pathological findings ( P < .05). As the COVID-19 progressed (pneumonia and respiratory failure), the degree of loss of smell increased ( P < .05). A statistically significant relationship was found between the CCCRC score and the presence of PNS CT findings ( P = .0012). Conclusion: The PNS CT findings are significant in patients with COVID-19 with a loss of smell and were significantly associated with the degree of loss of smell. In patients with olfactory loss due to COVID-19, PNS CT can help in diagnosis. However, for this imaging to be diagnostic, a larger patient series is needed.

Objective COVID-19 is an infectious disease caused by the new coronavirus that starts similar to an upper respiratory tract infection and causes death by causing pneumonia and vasculopathy. Many viral infections are known to cause hearing loss. In this study, pure-tone audiometry (PTA) thresholds and Transient Evoked Otoacoustic Emissions (TEOAE) results were compared across patients with COVID-19 disease and COVID-19 pneumonia, and control group patients. Methods The study included 240 patients in the age range of 18–50 years. The patients were divided into three groups of 80 patients as the control (no disease), COVID-19 (nonpneumonia), Covid-19 (pneumonia) groups. PTA and TEOAE tests were performed on the control group patients and the results were recorded. PTA and TEOAE tests were performed in the COVID-19 groups in the first and third months after the infection ended. Each test was performed twice; the results were recorded, and the mean of the two results was calculated. Results PTA results and TEOAE amplitudes in the first and third months were not significantly different between the COVID-19 non-pneumonia group and the control group ( p > 0.05), between the COVID-19 pneumonia group and the control group (p > 0.05), and between the COVID-19 non-pneumonia group and the COVID-19 pneumonia group ( p > 0.05). Conclusions Despite minimal impairment and minimal amplitude decreases in patients, who recovered from COVID-19, such changes were found to become restored in the third month. Furthermore, no significant changes were observed to indicate COVID-19- associated hearing loss.

Objective: COVID-19; It is an infectious disease that starts with cold symptoms and causes Acute Respiratory Failure, causing deaths all over the world. Besides the common symptoms of the disease such as fever, dyspnea and cough, recently, a “sudden loss of smell” has been added as a diagnostic symptom.Materials and Methods: Clinical and demographic features, Tomography results, and odor test scores of 40 patients diagnosed as sudden olfactory loss using Connecticut (CCCRC) Olfactory Test ”will be evaluated together, and odor disorder and clinical and radiological findings will be compared.Results: There was no significant difference in smell loss in terms of gender. No relationship was found between smoking and degree of smell disorder. (p> 0.05) When we evaluated the paranasal CTs taken from our patients with odor loss, 2 patients' CT showed pathological findings (p <0.05). As the patients' illness worsened, an increase in the degree of odor loss was observed (p <0.05). Between the CCCRC score and presence of PNS CT findings, a significant statistical relationship was found (p = 0.0012)Conclusion : Olfactory loss was not related to age, gender, smoking. PNS CT findings were significantly correlated with the degree of olfactory loss. In patients with olfactory loss, evaluation with a PNS CT may be diagnostic in terms of COVID-19. However, in order for this examination to be diagnostic, a larger patient series is needed.

Ana pulmoner arterden çıkan sol ana koroner arter anormalisi, çocuklarda çok nadir görülen bir doğuştan kalp hastalığıdır. Ölümcül iskemik ve aritmik komplikasyonlar genellikle pulmoner vasküler direncin düştüğü ve sol koroner arter akımının azaldığı erken bebeklik döneminde ortaya çıkar. Yaygın kollateral koroner arter dolaşım gelişirse, hastaların yaklaşık %10'u çocukluk ve yetişkinlik çağına ulaşır. Bu yazıda, 10 yaşındaki bir hastada sol internal mamaryan arterin sol ana koroner artere uygulanan uç uca anastomoz tekniğimiz sunuldu. Anah tar söz cük ler: ALCAPA; pulmoner arterden çıkan sol koroner arter anomalisi; doğuştan kalp hastalığı; koroner arter.

No abstract

No abstract